Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Meningococcal

View all HPV Plague Tetanus
Anthrax Influenza Pneumococcal Typhoid
Chickenpox Japanese encephalitis Polio Yellow fever
Diphtheria Measles Rabies Zoster
Hib Meningococcal Rotavirus
Hepatitis A Mumps Rubella
Hepatitis B Pertussis Smallpox
 

Recommendations - Meningococcal

Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530
HTML  |  PDF
 
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
 
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013; 62(3):52-4
HTML  |  PDF
 
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
 
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):273
HTML  |  PDF
 
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
Source: MMWR, September 25, 2009; 58(37):1042-1043
HTML  |  PDF
 
Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December 7, 2007; 56(48):1265-1266
HTML  |  PDF
 
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML  |  PDF
 
Prevention and Control of Meningococcal Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21
HTML  |  PDF
This page was reviewed on June 20, 2014
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.